Cilostazol

Product NDC
0093-2064
11-digit product format
000932064
Labeler code
0093
Product ID
0093-2064_01457771-0b8c-4f1b-8513-01ad09ac97cc
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cilostazol
Dosage form
TABLET
Route
ORAL
Labeler
Teva Pharmaceuticals USA, Inc.
Application
ANDA077027
Marketing category
ANDA
Marketing start
2012-10-24
Substance
CILOSTAZOL
Active strength
100 mg/1
Pharmacologic classes
Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Cilostazol
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CILOSTAZOL100 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiN7Z035406B
Rxcui242461, 242462

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c114def4-591e-cde9-1a9f-29af28d4c1eaProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0093-2064-06Cilostazol60 in 1 BOTTLETABLET6016
0093-2064-50Cilostazol5000 in 1 BOTTLETABLET500016

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0093-2064-06EA - Each0093-20641d9a640c-885b-4cdb-9776-37cd9a6992de12013-02-13
0093-2064-50EA - Each0093-2064602ca8fc-9a15-41dc-aac0-0c273e41726512013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CILOSTAZOLACTIVE INGREDIENTN7Z035406BCILOSTAZOL TABLET [TEVA PHARMACEUTICALS USA INC]7
CILOSTAZOLACTIVE MOIETYN7Z035406BCILOSTAZOL TABLET [TEVA PHARMACEUTICALS USA INC]7
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCILOSTAZOL TABLET [TEVA PHARMACEUTICALS USA INC]7
CROSPOVIDONEINACTIVE INGREDIENT68401960MKCILOSTAZOL TABLET [TEVA PHARMACEUTICALS USA INC]7
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30CILOSTAZOL TABLET [TEVA PHARMACEUTICALS USA INC]7
POVIDONE K30INACTIVE INGREDIENTU725QWY32XCILOSTAZOL TABLET [TEVA PHARMACEUTICALS USA INC]7
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4CILOSTAZOL TABLET [TEVA PHARMACEUTICALS USA INC]7
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJCILOSTAZOL TABLET [TEVA PHARMACEUTICALS USA INC]7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0093-2064CILOSTAZOL TABLET [TEVA PHARMACEUTICALS USA, INC.]16Current NDC, Legacy NDC, 2 package rows20230329_a6292311-9cb2-49ff-b8bf-12e2dbd196cd.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
242461cilostazol 100 MG Oral TabletPSN53486382-eee0-4cbe-bc4a-a57484e0d5a7104
242461cilostazol 100 MG Oral TabletSCD53486382-eee0-4cbe-bc4a-a57484e0d5a7104
242461cilostazol 100 MG Oral TabletPSNa6292311-9cb2-49ff-b8bf-12e2dbd196cd16
242462cilostazol 50 MG Oral TabletPSNa6292311-9cb2-49ff-b8bf-12e2dbd196cd16
242461cilostazol 100 MG Oral TabletSCDa6292311-9cb2-49ff-b8bf-12e2dbd196cd16
242462cilostazol 50 MG Oral TabletSCDa6292311-9cb2-49ff-b8bf-12e2dbd196cd16

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0093-2064-060009320640660 TABLET in 1 BOTTLE (0093-2064-06) 60 tablet2012-10-240000-00-00NoNoCurrent
0093-2064-50000932064505000 TABLET in 1 BOTTLE (0093-2064-50) 5000 tablet2012-10-240000-00-00NoNoCurrent